EMEA-001741-PIP01-14-M01

Key facts

Invented name
Active substance
Upadacitinib
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0363/2017
PIP number
EMEA-001741-PIP01-14-M01
Pharmaceutical form(s)
  • Age-appropriate oral solid dosage form
  • Tablet
Condition(s) / indication(s)
Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, psoriatic arthritis, spondyloarthritis and juvenile idiopathic arthritis)
Route(s) of administration
Oral use
Contact for public enquiries
AbbVie Ltd
Tel.: +44 1628408248
E-mail: paediatricteam@abbvie.com
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating